Trials / Completed
CompletedNCT01409018
Pharmacokinetics of Itraconazole in Pediatric Cancer Patients
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study investigated repeated-dose pharmacokinetics and safety of itraconazole and its active metabolite hydroxyitraconazole in pediatric cancer patients at risk for the development of invasive fungal disease.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Itraconazole | pharmacokinetics |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-12-01
- Completion
- 2011-12-01
- First posted
- 2011-08-03
- Last updated
- 2013-11-19
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01409018. Inclusion in this directory is not an endorsement.